The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
Open accessAbstract
Glucocorticosteroids are a group of structurally related molecules that includes natural hormones and synthetic drugs with a wide range of anti‐inflammatory potencies. For synthetic corticosteroid analogues it is commonly assumed that the therapeutic index cannot be improved by increasing their glucocorticoid receptor binding affinity. The validity of this assumption, particularly for inhaled corticosteroids, has not been fully explored. Inhaled corticosteroids exert their anti‐inflammatory activity locally in the airways, and hence this can be dissociated from their potential to cause systemic adverse effects. The molecular structural features that increase glucocorticoid receptor binding affinity and selectivity drive topical anti‐inflammatory activity. However, in addition, these structural modifications also result in physicochemical and pharmacokinetic changes that can enhance targeting to the airways and reduce systemic exposure. As a consequence, potency and therapeutic index can be correlated. However, this consideration is not reflected in asthma treatment guidelines that classify inhaled corticosteroid formulations as low‐, mid‐ and high dose, and imbed a simple dose equivalence approach where potency is not considered to affect the therapeutic index. This article describes the relationship between potency and therapeutic index, and concludes that higher potency can potentially improve the therapeutic index. Therefore, both efficacy and safety should be considered when classifying inhaled corticosteroid regimens in terms of dose equivalence. The historical approach to dose equivalence in asthma treatment guidelines is not appropriate for the wider range of molecules, potencies and device/formulations now available. A more robust method is needed that incorporates pharmacological principles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
British Guideline on the Management of Asthma
British Thoracic Society Scottish Intercollegiate Guidelines Network (2008) · Thorax · doi:10.1136/thx.2008.097741 · Cited by 2,021
Thorsson, L., Edsbacker, S., & Conradson, T. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07101839 · Cited by 391
Normal Organ Weights in Men: Part II—The Brain, Lungs, Liver, Spleen, and Kidneys
Molina, D. K., & DiMaio, V. J. M. (2012) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0b013e31823d29ad · Cited by 273
Holt, S., Herxheimer, A., Suder, A., Weatherall, M., Cheng, S., Shirtcliffe, P., & Beasley, R. (2001) · BMJ · doi:10.1136/bmj.323.7307.253 · Cited by 226
Brutsche, M. H., Brutsche, I. C., Munawar, M., Langley, S. J., Masterson, C. M., Daley-Yates, P. T., Brown, R., Custovic, A., & Woodcock, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02581-2 · Cited by 221
Self-citationPharmacokinetics and pharmacodynamics of inhaled corticosteroids
Derendorf, H., Hochhaus, G., Meibohm, B., Möllmann, H., & Barth, J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70156-3 · Cited by 216
Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network.
Kamada, A. K., Szefler, S. J., Martin, R. J., Boushey, H. A., Chinchilli, V. M., Drazen, J. M., Fish, J. E., Israel, E., Lazarus, S. C., & Lemanske, R. F. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.6.8665030 · Cited by 192
Mager, D. E., Lin, S. X., Blum, R. A., Lates, C. D., & Jusko, W. J. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258651 · Cited by 166
(2003) · Thorax · doi:10.1136/thorax.58.suppl_1.1i · Cited by 166
ANDERSON, P. J. (1997) · CHEST Journal · doi:10.1378/chest.111.5.1155 · Cited by 150
Cited by
A General Introduction to Glucocorticoid Biology
Timmermans, S., Souffriau, J., & Libert, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01545 · Cited by 609
Therapeutic Mechanisms of Glucocorticoids
Vandewalle, J., Luypaert, A., De Bosscher, K., & Libert, C. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.10.010 · Cited by 548
Clinical Pharmacology of Corticosteroids
Williams, D. M. (2018) · Respiratory Care · doi:10.4187/respcare.06314 · Cited by 460
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Borghardt, J. M., Kloft, C., & Sharma, A. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/2732017 · Cited by 304
The multiple roles of life stress in metabolic disorders
Kivimäki, M., Bartolomucci, A., & Kawachi, I. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00746-8 · Cited by 297
Martinez, F. J., Rabe, K. F., Ferguson, G. T., Wedzicha, J. A., Singh, D., Wang, C., Rossman, K., St. Rose, E., Trivedi, R., Ballal, S., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202006-2618oc · Cited by 269
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Adcock, I. M., & Mumby, S. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_98 · Cited by 131
Savas, M., Vinkers, C. H., Rosmalen, J. G. M., Hartman, C. A., Wester, V. L., van den Akker, E. L. T., Iyer, A. M., McEwen, B. S., & van Rossum, E. F. C. (2020) · Neuroendocrinology · doi:10.1159/000501617 · Cited by 55
Intranasal corticosteroids: topical potency, systemic activity and therapeutic index
Daley-Yates, P. T., Larenas-Linnemann, D., Bhargave, C., & Verma, M. (2021) · Journal of Asthma and Allergy · doi:10.2147/jaa.s321332 · Cited by 49
Self-citation
Metadata
- Authors
- Daley‐Yates, P. T.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2015-05-28
- Volume
- 80
- Issue
- 3
- Pages
- 372-380
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2143096094
- Cited by
- 260
- References
- 32
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.